S3 Ep39: Playing with a ‘Crappy’ Set of Cards Lung Cancer Dealt
Cancer Horizons19 Aug 2020

S3 Ep39: Playing with a ‘Crappy’ Set of Cards Lung Cancer Dealt

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Dan Tran, an oral and maxillofacial surgeon at VCU, about his journey with cancer and how his experience influenced his career in medicine.

Tran, who was in residency and about to begin a five-month rotation in anesthesia in the fall of 2017, developed back pain that was so excruciating it started to affect his ability to walk.

Within months, Tran started experiencing numbness in his legs when he decided to go to the emergency room to get checked out. After several tests, and just days before Christmas, Tran was diagnosed with stage 4 lung cancer at the age of 30.

Now, three years out from his diagnosis, Tran discusses what his journey was like, what it has been like to be a medical professional with cancer, and what advice he offers his patients who are coming in for treatments as a result of oral side effects of cancer treatment.

“Everyone gets dealt a different set of cards and I got delta a crappy hand,” said Tran in an interview with CURE®. “But, it kind of depends on what you do with it. I've always had a pretty laid-back kind of personality and understood that there's things that I can control and things I can't control. This is something I could not control, but I can control what I do with it.”

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Dec 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Mars 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Sep 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Mars 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Mars 202410min

S6 Ep20: FDA Approvals from February 2024

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Feb 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Feb 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Feb 20247min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
medicinvetarna
rss-ufobortom-rimligt-tvivel
bildningspodden
det-morka-psyket
svd-nyhetsartiklar
rss-spraket
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
rss-vetenskapsradion-2
barnpsykologerna
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
kapitalet-en-podd-om-ekonomi
dumforklarat
sexet
rss-lara-fran-larda-en-fackbok-och-en-forfattare
rss-personlighetspodden
ufo-sverige
rss-kriminologerna